Immunouniverse of SARS-CoV-2
AbstractSARS-CoV-2 virus has become a global health problem that has caused millions of deaths worldwide. The infection can present with multiple clinical features ranging from asymptomatic or mildly symptomatic patients to patients with severe or critical illness that can even lead to death. Althou...
Main Authors: | Dennis Jiménez, Marbel Torres Arias |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-10-01
|
Series: | Immunological Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/25785826.2022.2066251 |
Similar Items
-
Immunomodulatory Drugs in the Management of SARS-CoV-2
by: Daniel R. Burrage, et al.
Published: (2020-08-01) -
Immunomodulators and SARS-CoV-2: Management of the Dysregulated Immune Response
by: Chandramouli Mandya Thimmaiah, et al.
Published: (2023-04-01) -
Septic Hyperinflammation—Is There a Role for Extracorporeal Blood Purification Techniques?
by: Dominik Jarczak, et al.
Published: (2024-03-01) -
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
by: Aliakbar Hasankhani, et al.
Published: (2023-02-01) -
Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
by: Hi Eun Jung, et al.
Published: (2021-10-01)